Pharmaceutical company mesoestetic has introduced two new products for intradermal injection to its mesohyal range, mesohyal REDENX and mesohyal ARGIBENONE.
mesohyal REDENX is an antiageing solution, aimed at treating gravitational wrinkles whilst enhancing skin density and firmness. The company explains that it combines a tripeptide and a tetrapeptide to activate the synthesis proteins of the extracellular matrix, improving the redensification biological mechanisms impaired by the reduction of oestrogens and other factors characteristic of ageing.
Mesohyal ARGIBENONE is an antiaging, antioxidant solution aimed at reducing dynamic expression lines and photo-induced damage. by combining a biomimetic hexapeptide, idebenone, with hyaluronic acid. This acts on the formation process of expression lines and on the key cell pathways that are altered during the aging process, the company claims.
Adam Birtwistle, managing director of mesoestetic UK, said, “Our two new ampoules, mesohyal™ REDENX and mesohyal™ ARGIBENONE represent a new generation of biological active ingredients formulated with biomimetic peptides, expect the high quality and results associated with products from mesoestetic combined with care and innovation. These two products alone offer the complete antiageing solution, with particular reference to the often-neglected needs of menopausal skin.”
